Mingsight Pharmaceuticals

San Diego, United States

Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.

$20.0M raised

Nov 2021

Series B

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Kaitai Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mingsight Pharmaceuticals

How much funding has Mingsight Pharmaceuticals raised?

Mingsight Pharmaceuticals has raised $20.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are Mingsight Pharmaceuticals's investors?

Mingsight Pharmaceuticals's investors include Kaitai Capital.

Where is Mingsight Pharmaceuticals headquartered?

Mingsight Pharmaceuticals is headquartered in San Diego, United States.

What does Mingsight Pharmaceuticals do?

Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.

What stage is Mingsight Pharmaceuticals at?

Mingsight Pharmaceuticals is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 9, 2021.

MLA

"Mingsight Pharmaceuticals — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/mingsight-pharmaceuticals. Accessed July 3, 2026.

APA

VCBacked. (2021). Mingsight Pharmaceuticals — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/mingsight-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Mingsight Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/mingsight-pharmaceuticals |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 9, 2021.